CHAPTER 1. INTRODUCTION

1.1. RESEARCH OBJECTIVE

1.2. SCOPE OF THE STUDY

1.3. DEFINITION

CHAPTER 2. RESEARCH METHODOLOGY

2.1. RESEARCH APPROACH

2.2. DATA SOURCES

2.3. ASSUMPTIONS & LIMITATIONS

CHAPTER 3. EXECUTIVE SUMMARY

3.1. MARKET SNAPSHOT

CHAPTER 4. MARKET VARIABLES AND SCOPE 

4.1. INTRODUCTION

4.2. MARKET CLASSIFICATION AND SCOPE

4.3. INDUSTRY VALUE CHAIN ANALYSIS

4.3.1. RAW MATERIAL PROCUREMENT ANALYSIS 

4.3.2. SALES AND DISTRIBUTION CHANNEL ANALYSIS

4.3.3. DOWNSTREAM BUYER ANALYSIS

CHAPTER 5. COVID 19 IMPACT ON COSMETIC SURGERY MARKET 

5.1. COVID-19 LANDSCAPE: COSMETIC SURGERY INDUSTRY IMPACT

5.2. COVID 19 - IMPACT ASSESSMENT FOR THE INDUSTRY

5.3. COVID 19 IMPACT: GLOBAL MAJOR GOVERNMENT POLICY

5.4. MARKET TRENDS AND OPPORTUNITIES IN THE COVID-19 LANDSCAPE

CHAPTER 6. MARKET DYNAMICS ANALYSIS AND TRENDS

6.1. MARKET DYNAMICS

6.1.1. MARKET DRIVERS

6.1.2. MARKET RESTRAINTS

6.1.3. MARKET OPPORTUNITIES

6.2. PORTER’S FIVE FORCES ANALYSIS

6.2.1. BARGAINING POWER OF SUPPLIERS

6.2.2. BARGAINING POWER OF BUYERS

6.2.3. THREAT OF SUBSTITUTE

6.2.4. THREAT OF NEW ENTRANTS

6.2.5. DEGREE OF COMPETITION

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1.1. COMPANY MARKET SHARE/POSITIONING ANALYSIS

7.1.2. KEY STRATEGIES ADOPTED BY PLAYERS

7.1.3. VENDOR LANDSCAPE

7.1.3.1. LIST OF SUPPLIERS

7.1.3.2. LIST OF BUYERS

CHAPTER 8. GLOBAL COSMETIC SURGERY MARKET, BY PROCEDURE

8.1. COSMETIC SURGERY MARKET, BY PROCEDURE, 2024-2033

8.1.1. SURGICAL PROCEDURES

8.1.1.1. MARKET REVENUE AND FORECAST (2025-2033)

8.1.2. NON-SURGICAL PROCEDURES

8.1.2.1. MARKET REVENUE AND FORECAST (2025-2033)

CHAPTER 9. GLOBAL COSMETIC SURGERY MARKET, BY GENDER

9.1. COSMETIC SURGERY MARKET, BY GENDER, 2024-2033

9.1.1. MALE

9.1.1.1. MARKET REVENUE AND FORECAST (2025-2033)

9.1.2. FEMALE

9.1.2.1. MARKET REVENUE AND FORECAST (2025-2033)

CHAPTER 10. GLOBAL COSMETIC SURGERY MARKET, BY AGE 

10.1. COSMETIC SURGERY MARKET, BY AGE, 2024-2033

10.1.1. 18 YEARS AND YOUNGER

10.1.1.1. MARKET REVENUE AND FORECAST (2025-2033)

10.1.2. 19 TO 34 YEARS

10.1.2.1. MARKET REVENUE AND FORECAST (2025-2033)

10.1.3. 35 TO 50 YEARS

10.1.3.1. MARKET REVENUE AND FORECAST (2025-2033)

10.1.4. 51 TO 64 YEARS

10.1.4.1. MARKET REVENUE AND FORECAST (2025-2033)

10.1.5. 65 YEARS & ABOVE

10.1.5.1. MARKET REVENUE AND FORECAST (2025-2033)

CHAPTER 11. GLOBAL COSMETIC SURGERY MARKET, BY PROVIDER

11.1. COSMETIC SURGERY MARKET, BY PROVIDER, 2024-2033

11.1.1. HOSPITALS & SPECIALTY CLINICS

11.1.1.1. MARKET REVENUE AND FORECAST (2025-2033)

11.1.2. SPAS & COSMETIC SURGERY CENTERS

11.1.2.1. MARKET REVENUE AND FORECAST (2025-2033)

CHAPTER 12. GLOBAL COSMETIC SURGERY MARKET, REGIONAL ESTIMATES AND TREND FORECAST

12.1. NORTH AMERICA

12.1.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.1.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.1.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.1.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.1.5. U.S.

12.1.5.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.1.5.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.1.5.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.1.5.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.1.6. REST OF NORTH AMERICA

12.1.6.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.1.6.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.1.6.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.1.6.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.2. EUROPE

12.2.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.2.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.2.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.2.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.2.5. UK

12.2.5.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.2.5.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.2.5.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.2.5.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.2.6. GERMANY

12.2.6.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.2.6.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.2.6.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.2.6.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.2.7. FRANCE

12.2.7.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.2.7.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.2.7.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.2.7.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.2.8. REST OF EUROPE

12.2.8.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.2.8.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.2.8.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.2.8.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.3. APAC

12.3.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.3.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.3.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.3.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.3.5. INDIA

12.3.5.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.3.5.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.3.5.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.3.5.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.3.6. CHINA

12.3.6.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.3.6.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.3.6.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.3.6.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.3.7. JAPAN

12.3.7.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.3.7.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.3.7.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.3.7.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.3.8. REST OF APAC

12.3.8.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.3.8.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.3.8.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.3.8.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.4. MEA

12.4.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.4.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.4.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.4.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.4.5. GCC

12.4.5.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.4.5.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.4.5.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.4.5.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.4.6. NORTH AFRICA

12.4.6.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.4.6.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.4.6.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.4.6.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.4.7. SOUTH AFRICA

12.4.7.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.4.7.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.4.7.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.4.7.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.4.8. REST OF MEA

12.4.8.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.4.8.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.4.8.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.4.8.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.5. LATIN AMERICA

12.5.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.5.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.5.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.5.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.5.5. BRAZIL

12.5.5.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.5.5.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.5.5.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.5.5.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

12.5.6. REST OF LATAM

12.5.6.1. MARKET REVENUE AND FORECAST, BY PROCEDURE (2025-2033)

12.5.6.2. MARKET REVENUE AND FORECAST, BY GENDER (2025-2033)

12.5.6.3. MARKET REVENUE AND FORECAST, BY AGE (2025-2033)

12.5.6.4. MARKET REVENUE AND FORECAST, BY END USER (2025-2033)

CHAPTER 13. COMPANY PROFILES

13.1. EVOLUS INC.

13.1.1. COMPANY OVERVIEW

13.1.2. PRODUCT OFFERINGS

13.1.3. FINANCIAL PERFORMANCE

13.1.4. RECENT INITIATIVES

13.2. REVANCE GALDERMA

13.2.1. COMPANY OVERVIEW

13.2.2. PRODUCT OFFERINGS

13.2.3. FINANCIAL PERFORMANCE

13.2.4. RECENT INITIATIVES

13.3. ABBVIE

13.3.1. COMPANY OVERVIEW

13.3.2. PRODUCT OFFERINGS

13.3.3. FINANCIAL PERFORMANCE

13.3.4. RECENT INITIATIVES

13.4. CYNOSURE

13.4.1. COMPANY OVERVIEW

13.4.2. PRODUCT OFFERINGS

13.4.3. FINANCIAL PERFORMANCE

13.4.4. RECENT INITIATIVES

13.5. LUMENIS

13.5.1. COMPANY OVERVIEW

13.5.2. PRODUCT OFFERINGS

13.5.3. FINANCIAL PERFORMANCE

13.5.4. RECENT INITIATIVES

13.6. SOLTA MEDICAL

13.6.1. COMPANY OVERVIEW

13.6.2. PRODUCT OFFERINGS

13.6.3. FINANCIAL PERFORMANCE

13.6.4. RECENT INITIATIVES

13.7. ALMA LASER

13.7.1. COMPANY OVERVIEW

13.7.2. PRODUCT OFFERINGS

13.7.3. FINANCIAL PERFORMANCE

13.7.4. RECENT INITIATIVES

13.8. SYNERON CANDELA

13.8.1. COMPANY OVERVIEW

13.8.2. PRODUCT OFFERINGS

13.8.3. FINANCIAL PERFORMANCE

13.8.4. RECENT INITIATIVES

CHAPTER 14. RESEARCH METHODOLOGY

14.1. PRIMARY RESEARCH

14.2. SECONDARY RESEARCH

14.3. ASSUMPTIONS

CHAPTER 15. APPENDIX

15.1. ABOUT US

15.2. GLOSSARY OF TERMS